Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) reached a new 52-week low during trading on Tuesday . The company traded as low as C$0.09 and last traded at C$0.10, with a volume of 37646 shares trading hands. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Down 5.0%
The firm has a market capitalization of C$17.05 million, a price-to-earnings ratio of -9.50 and a beta of 1.07. The business has a 50 day simple moving average of C$0.12 and a 200-day simple moving average of C$0.14. The company has a debt-to-equity ratio of 6.05, a quick ratio of 0.84 and a current ratio of 0.18.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
